Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Editor's Corner


headshot

FOMO No Mo!

July 2024
Aaron Gerds, MD

Dr. Gerds discusses the fear of missing out (FOMO) and how to overcome it in your career.

Which Inhibitor Should Be Used to Treat FLT3-Positive AML?

July 2024

Elizabeth Griffiths, MD, and Alex Ambinder, MD, MPH, discuss what we do and don’t yet know about FLT3 inhibitors in the treatment of acute myeloid leukemia (AML).

Shaping Future Hematologists

July 2024

Marvin Nieman, PhD, talks about running a lab, overseeing PhD and master’s programs, and spending time with his family.

GABARAP Deficiency May Contribute to Bortezomib Resistance in Multiple Myeloma

July 2024

Loss of GABA type A receptor-associated protein (GABARAP) was associated with impaired immunogenic cell death signaling and shorter multiple myeloma survival.

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals